TrialJournal of gynecologic oncology2021

Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer.

Kazuhiro Takehara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.